Association Between Inflammatory Biomarkers in CVD Patients on Empagliflozin.

NCT05911724 · clinicaltrials.gov ↗

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Stable Angina
Heart Failure

Interventions

OTHER: Group I Healthy
DRUG: CAD-Empagliflozin 10 mg once daily for 6 months before the beginning of the study
DRUG: HF-Empagliflozin 10 mg once daily for 6 months before the beginning of the study

Sponsor

Damanhour University

Collaborators

[object Object]